"Medicinal Cannabis: Diabetes, Glaucoma, and Hypertension" is an in-depth course that examines the role of cannabinoids in managing chronic conditions. This course provides a scientific framework for understanding the pharmacology of cannabis and its applications in improving patient outcomes. Participants will gain insights into the adjunctive use of cannabinoids alongside conventional therapies.
Unit 1: Diabetes, Glaucoma, and Hypertension
This foundational unit provides an overview of diabetes (type 1 and type 2), glaucoma, and hypertension. Key topics include:
- The pathophysiology and prevalence of these conditions
- Their shared comorbidities and the impact on overall health
- Conventional management strategies, including pharmacological and lifestyle interventions
- The challenges posed by vision impairment, neuropathy, and cardiovascular complications.
Unit 2: Prevention and Treatment
This unit emphasises the importance of prevention and comprehensive treatment strategies:
- Lifestyle interventions such as hypocaloric diets (e.g., the Mediterranean diet) and physical activity to enhance insulin sensitivity and cardiovascular health
- An overview of pharmacological treatments for diabetes and hypertension, including insulin sensitisers, GLP-1 receptor agonists, and antihypertensive drugs
- The interconnected role of metabolic syndrome, obesity, and diabetes in exacerbating cardiovascular risks.
Unit 3: The Pharmacology of Cannabis
A deep dive into the pharmacological properties of cannabinoids:
- The endocannabinoid system and its role in metabolic regulation, immune modulation, and pain management
- The specific properties and clinical applications of major cannabinoids like THC, CBD, and THCV
- Evidence from preclinical and clinical studies on the use of cannabinoids in managing diabetes, glaucoma, and hypertension
- Challenges in cannabinoid therapy, including dosage optimisation, solubility issues, and potential side effects.
Unit 4: Cannabis in Diabetes Treatment
Focused on case-based applications of medicinal cannabis:
- How cannabinoids such as THC and CBD can alleviate diabetes-related symptoms like neuropathic pain, restless legs syndrome, and vascular complications
- Detailed case studies demonstrating reductions in pain, blood pressure, and medication dependency with adjunctive cannabis therapy
- Insights into the potential weight loss benefits and metabolic improvements associated with cannabinoid use
- Guidelines for monitoring patient outcomes and integrating cannabis into a broader treatment plan.
This course combines evidence-based research, clinical examples, and practical strategies to empower healthcare professionals in using medicinal cannabis as a safe and effective adjunct therapy. It is designed to ensure learners are equipped with the knowledge to support their patients responsibly while advancing their practice.
Learning Outcomes
- Manage diabetes with medicinal cannabis
- Manage glaucoma and hypertension with medicinal cannabis.
Details
Cost: Please refer to Healthcert's website
Suitable for: All degree qualified medical practitioners
Study mode: 100% online
Disclaimer: Please note, once you click 'Register now' you will be leaving the AMA’s CPD Home website and entering a third-party education provider’s website. If you choose to register for this learning, you will need to provide some of your personal information directly to the third-party education provider. If you have any queries about how third-party education providers use, disclose or store your personal information you should consult their privacy policy.
Upon completion, your CPD activity record may take up to 4 weeks to be reflected on your CPD Home Dashboard.